The relationship between inflammation and new bone formation in patients with ankylosing spondylitis

[1]  B. Dijkmans,et al.  Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period. , 2008, Arthritis and rheumatism.

[2]  D. M. van der Heijde,et al.  Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. , 2008, Arthritis and rheumatism.

[3]  J. Braun,et al.  Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. , 2008, Arthritis and rheumatism.

[4]  P. Villiger,et al.  Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis , 2007, Annals of the rheumatic diseases.

[5]  D. M. van der Heijde,et al.  Tumour necrosis factor blockers and structural remodelling in ankylosing spondylitis: what is reality and what is fiction? , 2007, Annals of the rheumatic diseases.

[6]  J. Braun,et al.  Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes , 2007, Annals of the rheumatic diseases.

[7]  F. Luyten,et al.  Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. , 2007, Arthritis and rheumatism.

[8]  Georg Schett,et al.  Dickkopf-1 is a master regulator of joint remodeling , 2007, Nature Medicine.

[9]  H. Stein,et al.  Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis , 2006, Arthritis research & therapy.

[10]  R. Landewé,et al.  Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. , 2006, Arthritis and rheumatism.

[11]  John Han,et al.  Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. , 2006, Arthritis and rheumatism.

[12]  J. Braun,et al.  Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data. , 2005, Arthritis and rheumatism.

[13]  J. Braun,et al.  Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab. , 2005, Rheumatology.

[14]  J. Braun,et al.  Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor α in two patients with early disease and transforming growth factor β in three more advanced cases , 2005, Annals of the rheumatic diseases.

[15]  S. van der Linden,et al.  Combining information obtained from magnetic resonance imaging and conventional radiographs to detect sacroiliitis in patients with recent onset inflammatory back pain , 2005, Annals of the rheumatic diseases.

[16]  M. Dougados,et al.  Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation? , 2005, Annals of the rheumatic diseases.

[17]  F. Luyten,et al.  Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. , 2005, The Journal of clinical investigation.

[18]  M. Dougados,et al.  Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks , 2005, Annals of the rheumatic diseases.

[19]  John C. Davis,et al.  Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor α receptor fusion protein etanercept , 2005 .

[20]  J. Braun,et al.  Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor α antibody infliximab , 2005 .

[21]  J. Braun,et al.  Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept , 2005, Annals of the rheumatic diseases.

[22]  B. Dijkmans,et al.  Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). , 2005, Arthritis and rheumatism.

[23]  D. M. van der Heijde,et al.  Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging ( MRI ) – a comparison between contrast enhanced T 1 and short-tau inversion recovery ( STIR ) sequences , 2005 .

[24]  D. M. van der Heijde,et al.  Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging , 2004, Annals of the rheumatic diseases.

[25]  M. Dougados,et al.  What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. , 2004, Arthritis and rheumatism.

[26]  D. M. van der Heijde,et al.  Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems , 2004, Annals of the rheumatic diseases.

[27]  M. A. van 't Hof,et al.  Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system , 2004, Annals of the rheumatic diseases.

[28]  H. Zeidler,et al.  Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial. , 2003, Arthritis and rheumatism.

[29]  R. Porcher,et al.  Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α , 2003, Annals of the rheumatic diseases.

[30]  D. M. van der Heijde,et al.  Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. , 2003, Arthritis and rheumatism.

[31]  D. M. van der Heijde,et al.  Imaging and scoring in ankylosing spondylitis. , 2002, Clinical and experimental rheumatology.

[32]  H. Zeidler,et al.  Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial , 2002, The Lancet.

[33]  J. Braun,et al.  Radiologic diagnosis and pathology of the spondyloarthropathies. , 1998, Rheumatic diseases clinics of North America.

[34]  J. Braun,et al.  The sacroiliac joint in the spondyloarthropathies , 1996, Current opinion in rheumatology.

[35]  J. Braun,et al.  Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. , 1995, Arthritis and rheumatism.

[36]  A. Cats,et al.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.

[37]  B. Engfeldt,et al.  Histological Studies of Pelvo-Spondylitis Ossificans (Ankylosing Spondylitis) correlated with Clinical and Radiological Findings , 1954, Annals of the rheumatic diseases.

[38]  D. M. van der Heijde,et al.  Inflammatory biomarkers , disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab , 2008 .

[39]  M. Dougados,et al.  Radiological scoring methods in ankylosing spondylitis. Reliability and change over 1 and 2 years. , 2004, The Journal of rheumatology.

[40]  J. Braun,et al.  Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. , 1998, Arthritis and rheumatism.

[41]  R. Romanus,et al.  Destructive and ossifying spondylitic changes in rheumatoid ankylosing spondylitis (pelvo-spondylitis ossificans). , 1952, Acta orthopaedica Scandinavica.

[42]  J. Braun,et al.  Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF- a antibody infliximab , 2022 .